Quince Therapeutics Stock Forecast

Buy candidate since Nov 17, 2025

The Quince Therapeutics, Inc. stock price gained 7.14% on the last trading day (Monday, 17th Nov 2025), rising from $1.68 to $1.80. During the last trading day the stock fluctuated 11.61% from a day low at $1.68 to a day high of $1.88. The price has fallen in 5 of the last 10 days but is still up by 10.43% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 139 thousand more shares were traded than the day before. In total, 422 thousand shares were bought and sold for approximately $760.12 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.72% during the next 3 months and, with a 90% probability hold a price between $1.71 and $2.30 at the end of this 3-month period.

QNCX Signals & Forecast

Mostly positive signals in the chart today. The Quince Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $1.69 and $1.76. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, November 07, 2025, and so far it has risen 15.38%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Quince Therapeutics, Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. The stock had a Golden Star Signal on Wednesday, October 01, 2025 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for Quince Therapeutics, Inc. stock

Quince Therapeutics, Inc. finds support from accumulated volume at $1.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.195 between high and low, or 11.61%. For the last week, the stock has had daily average volatility of 13.98%.

Our recommended stop-loss: $1.73 (-3.90%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (QNCX) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Quince Therapeutics, Inc. to open at $1.79, and during the day (based on 14 day Average True Range), to move between $1.73 and $1.87, which gives a possible trading interval of +/-$0.134 (+/-7.72%) up or down from last closing price. If Quince Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 7.72% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.82 (1.11%) than the support at $1.78 (1.11%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Quince Therapeutics, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Quince Therapeutics, Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 4.166 Buy Candidate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $1.79 ( 0.83%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk